In Silico Selection and In Vitro Evaluation of New Molecules That Inhibit the Adhesion of Streptococcus mutants through Antigen I/II.
Raúl E Rivera-QuirogaNéstor CardonaLeonardo PadillaWbeimar RiveraCristian Rocha-RoaMayri A Díaz De RienzoSandra M MoralesMaría C MartinezPublished in: International journal of molecular sciences (2020)
Streptococcus mutans is the main early colonizing cariogenic bacteria because it recognizes salivary pellicle receptors. The Antigen I/II (Ag I/II) of S. mutans is among the most important adhesins in this process, and is involved in the adhesion to the tooth surface and the bacterial co-aggregation in the early stage of biofilm formation. However, this protein has not been used as a target in a virtual strategy search for inhibitors. Based on the predicted binding affinities, drug-like properties and toxicity, molecules were selected and evaluated for their ability to reduce S. mutans adhesion. A virtual screening of 883,551 molecules was conducted; cytotoxicity analysis on fibroblast cells, S. mutans adhesion studies, scanning electron microscopy analysis for bacterial integrity and molecular dynamics simulation were also performed. We found three molecules ZINC19835187 (ZI-187), ZINC19924939 (ZI-939) and ZINC19924906 (ZI-906) without cytotoxic activity, which inhibited about 90% the adhesion of S. mutans to polystyrene microplates. Molecular dynamic simulation by 300 nanoseconds showed stability of the interaction between ZI-187 and Ag I/II (PDB: 3IPK). This work provides new molecules that targets Ag I/II and have the capacity to inhibit in vitro the S. mutans adhesion on polystyrene microplates.
Keyphrases
- biofilm formation
- pseudomonas aeruginosa
- candida albicans
- staphylococcus aureus
- escherichia coli
- early stage
- electron microscopy
- molecular dynamics simulations
- molecular docking
- oxide nanoparticles
- quantum dots
- transcription factor
- cell cycle arrest
- squamous cell carcinoma
- cell death
- mass spectrometry
- cell proliferation
- signaling pathway
- case control
- neoadjuvant chemotherapy
- protein protein
- cell migration
- binding protein
- locally advanced